Ghost Tree Capital as of March 31, 2015
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 62 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Series Trust S&p Biotech Put Option (XBI) | 8.1 | $23M | 100k | 225.50 | |
| NuVasive | 4.3 | $12M | 260k | 45.99 | |
| Zimmer Holdings (ZBH) | 4.2 | $12M | 100k | 117.52 | |
| Actavis SHS | 3.7 | $10M | 35k | 297.63 | |
| Avalanche Biotechnologies In | 3.1 | $8.5M | 210k | 40.52 | |
| Endo Health Solutions Note 1.750% 4/1 | 2.9 | $8.1M | 90k | 89.70 | |
| Community Health Systems (CYH) | 2.8 | $7.8M | 150k | 52.28 | |
| Puma Biotechnology (PBYI) | 2.5 | $7.1M | 30k | 236.10 | |
| Zs Pharma | 2.5 | $6.9M | 165k | 42.08 | |
| Zeltiq Aesthetics | 2.5 | $6.9M | 225k | 30.83 | |
| Celgene Corporation | 2.5 | $6.9M | 60k | 115.28 | |
| Portola Pharmaceuticals | 2.5 | $6.8M | 180k | 37.96 | |
| Sage Therapeutics (SAGE) | 2.2 | $6.0M | 120k | 50.23 | |
| Dyax | 2.1 | $5.9M | 350k | 16.75 | |
| Merit Medical Systems (MMSI) | 2.1 | $5.8M | 300k | 19.25 | |
| Merck & Co (MRK) | 2.1 | $5.7M | 100k | 57.48 | |
| Wright Medical | 1.9 | $5.2M | 200k | 25.80 | |
| Becton, Dickinson and (BDX) | 1.8 | $5.0M | 35k | 143.60 | |
| Genocea Biosciences | 1.8 | $5.0M | 420k | 11.86 | |
| Alcobra SHS | 1.6 | $4.5M | 800k | 5.63 | |
| BioMarin Pharmaceutical (BMRN) | 1.6 | $4.4M | 35k | 124.63 | |
| Sunesis Pharmaceuticals Com New | 1.5 | $4.3M | 1.8M | 2.45 | |
| Cepheid | 1.5 | $4.3M | 75k | 56.91 | |
| Alnylam Pharmaceuticals (ALNY) | 1.5 | $4.2M | 40k | 104.42 | |
| Agilent Technologies Inc C ommon Call Option (A) | 1.5 | $4.2M | 100k | 41.55 | |
| Revance Therapeutics (RVNC) | 1.5 | $4.1M | 200k | 20.73 | |
| Gw Pharmaceuticals Ads | 1.5 | $4.1M | 45k | 91.13 | |
| Abbvie (ABBV) | 1.5 | $4.1M | 70k | 58.54 | |
| Acadia Healthcare (ACHC) | 1.4 | $3.9M | 120k | 32.59 | |
| EXACT Sciences Corporation (EXAS) | 1.4 | $3.9M | 175k | 22.02 | |
| Amicus Therapeutics (FOLD) | 1.4 | $3.8M | 350k | 10.88 | |
| Achillion Pharmaceuticals | 1.3 | $3.7M | 375k | 9.86 | |
| Ptc Therapeutics I (PTCT) | 1.3 | $3.7M | 60k | 60.85 | |
| Therapeuticsmd | 1.3 | $3.6M | 600k | 6.05 | |
| Bluebird Bio (BLUE) | 1.3 | $3.6M | 30k | 120.77 | |
| Flamel Technologies Sa Sponsored Adr | 1.3 | $3.6M | 200k | 17.98 | |
| Inogen (INGN) | 1.3 | $3.5M | 110k | 31.99 | |
| Vitae Pharmaceuticals | 1.3 | $3.5M | 300k | 11.71 | |
| Dbv Technologies S A Sponsored Adr (DBVT) | 1.3 | $3.5M | 150k | 23.36 | |
| Nanostring Technologies (NSTGQ) | 1.2 | $3.4M | 335k | 10.19 | |
| Entellus Medical Cm | 1.2 | $3.3M | 150k | 21.90 | |
| Radius Health Com New | 1.1 | $3.1M | 75k | 41.16 | |
| Discovery Laboratories Inc N Com New | 1.1 | $3.0M | 2.5M | 1.19 | |
| Pernix Therapeutics Holdings | 1.0 | $2.7M | 250k | 10.69 | |
| Ignyta | 0.9 | $2.5M | 250k | 9.95 | |
| Lion Biotechnologies | 0.9 | $2.4M | 200k | 12.11 | |
| Tetraphase Pharmaceuticals | 0.9 | $2.4M | 65k | 36.65 | |
| Applied Genetic Technol Corp C | 0.8 | $2.3M | 117k | 19.99 | |
| Five Prime Therapeutics | 0.8 | $2.3M | 100k | 22.85 | |
| Loxo Oncology | 0.8 | $2.2M | 175k | 12.45 | |
| Epizyme | 0.8 | $2.2M | 115k | 18.78 | |
| BioDelivery Sciences International Call Option | 0.8 | $2.1M | 200k | 10.50 | |
| Celladon | 0.7 | $1.9M | 100k | 18.94 | |
| Advaxis Com New | 0.6 | $1.8M | 125k | 14.44 | |
| Unilife US | 0.6 | $1.8M | 450k | 4.01 | |
| Insulet Corporation (PODD) | 0.6 | $1.7M | 50k | 33.36 | |
| Assembly Biosciences | 0.6 | $1.7M | 125k | 13.24 | |
| Kindred Biosciences | 0.3 | $718k | 101k | 7.14 | |
| Biolase Technology | 0.2 | $606k | 300k | 2.02 | |
| Ocera Therapeutics | 0.2 | $589k | 125k | 4.71 | |
| Globeimmune (GBIM) | 0.2 | $506k | 69k | 7.34 | |
| XOMA CORP Common equity shares | 0.1 | $262k | 72k | 3.64 |
